Cargando…
High expression of transcription factor POU2F1 confers improved survival on smokers with lung adenocarcinoma: a retrospective study of two cohorts
BACKGROUND: Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality worldwide and its most important risk factor is tobacco smoking. While smoking is associated with inferior outcome in NSCLC patients, smoking also correlates with a higher tumor mutational burden. In cont...
Autores principales: | Schulze, Arik Bernard, Wenge, Daniela Vanessa, Evers, Georg, Heitkötter, Birthe, Bleckmann, Annalen, Schmidt, Lars Henning, Mohr, Michael, Hartmann, Wolfgang, Arteaga, Maria Francisca, Mikesch, Jan-Henrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183409/ https://www.ncbi.nlm.nih.gov/pubmed/37197633 http://dx.doi.org/10.21037/tlcr-22-714 |
Ejemplares similares
-
High Expression of NT5DC2 Is a Negative Prognostic Marker in Pulmonary Adenocarcinoma
por: Schulze, Arik Bernard, et al.
Publicado: (2022) -
Tumor infiltrating T cells influence prognosis in stage I–III non-small cell lung cancer
por: Schulze, Arik Bernard, et al.
Publicado: (2020) -
Liquid Biopsies in Lung Cancer
por: Kemper, Marcel, et al.
Publicado: (2023) -
Prognostic impact of CD34 and SMA in cancer‐associated fibroblasts in stage I–III NSCLC
por: Schulze, Arik Bernard, et al.
Publicado: (2019) -
Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition
por: Kemper, Marcel, et al.
Publicado: (2021)